VM:CC - Voyageur Pharmaceuticals Ltd. Announces Issuance of Shares to Pay for Deposits and Debt
(TheNewswire)
News Release – Calgary, Alberta– TheNewswire - May 10, 2022: Voyageur Pharmaceuticals Ltd. (TSXV:VM) (USA:VYYRF) (the "Company" or"Voyageur") has agreed to pay deposits for work on design ofthe Company's manufacturing facility and pay other existing debts inan amount of up to $100,000 through the issuance of common shares ofthe Company ("Common Shares") at a deemed price per share of$0.11 based on the closing price of the Common Shares at the close oftrading on May 10, 2022 (the "Share Payments").
The Share Payments are subject to regulatory approval,including the approval of the TSX Venture Exchange. The Common Sharesissued pursuant to the Share Payments are subject to a four month holdperiod from the date of issuance.
About Voyageur
Voyageur is a Canadian public company listed on theTSXV under the trading symbol VM. Voyageur is focused on thedevelopment of barite and iodine Active Pharmaceutical Ingredients(“API”) and high-performance cost-effective imaging contrastagents for the medical radiology marketplace. Voyageur’s goal is toinitially generate positive cash flow from operations using thirdparty GMP pharmaceutical manufacturers in Canada and internationally.Ultimately, Voyageur has plans to build all the requiredinfrastructure to become 100% self-sufficient with all manufacturing.Voyageur owns a 100% interest in three barium sulphate (barite)projects including the Frances Creek property, suitable in grade forthe pharmaceutical barite marketplace, with interests in a high-gradeiodine, lithium & bromine brine project located in Utah,USA.
Voyageur is moving forward with its business plan ofbecoming the only fully integrated company in the radiology medicalfield, by controlling all primary input costs under the motto of:"From the Earth to the Bottle".
For Further MediaInformation or to set up an interview, please contact:
BrentWillis
President &CEO
www.voyageurpharmaceuticals.ca
Ron Love
CFO
T403.818.6086
Neither the TSX Venture Exchange norits Regulation Services Provider (as that term is defined in thepolicies of the TSX Venture Exchange) accepts responsibility for theadequacy or accuracy of this news release.
Cautionary Statement Regarding“Forward-Looking” Information
This news releasemay contain certain forward-looking information and statements,including without limitation the receipt of regulatory approval forthe issuance of the Share Payments. All statements included herein,other than statements of historical fact, are forward-lookinginformation and such information involves various risks anduncertainties. There can be no assurance that such information willprove to be accurate, and actual results and future events coulddiffer materially from those anticipated in such information. Adescription of assumptions used to develop such forward-lookinginformation and a description of risk factors that may cause actualresults to differ materially from forward-looking information can befound in the Company's disclosure documents on the SEDAR website atwww.sedar.com. Voyageur does not undertake to update anyforward-looking information except in accordance with applicablesecurities laws.
Copyright (c) 2022 TheNewswire - All rights reserved.